Cold-EEZE

Manufacturer: ProPhase Labs, Inc. | Pharmaloz Manufacturing, Inc.
Effective date: 2014-11-24
Label type: HUMAN OTC DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-06-01 02:06:19

Label at a glance#

ProductCold-EEZE Natural Multi-Symptom Relief

Active ingredientZinc Gluconate, Sambucus Nigra Flower, Eupatorium Perfoliatum Flowering Top, Mentha Piperita, Myrrh, Glycyrrhiza Glabra Leaf

Label structure10 sections

Indications and uses

Take one QuickMelt every 2-4 hours per Directions on other side. to reduce the duration of the common cold reduces the severity of cold and flu symptoms: cough, sore throat, nasal and chest congestion post nasal drip and/or hoarseness helps for temporary relief of Sore Throat

Dosage and administration

Take Cold-EEZE ® Plus Multi-Symptom Relief Cold & Flu QuickMelts ® when you have cold or flu symptoms Adults: Dissolve entire tablet in mouth. Do not chew. Do not swallow whole Take 1 tablet at the onset of symptoms Repeat every 2-4 hours as needed until all symptoms subside Do not eat or drink for 15 minutes after use, otherwise, drink plenty of fluids Recommended daily dose is 6 tablets for adults and 4 tablets ...

Storage and handling

Do not take Cold-EEZE ® Plus Multi-Symptom Relief Cold & Flu QuickMelts ® on an empty stomach to avoid possible minor stomach upset Store in a cool and dry place

Contacts and useful links#

PhoneLabel contact1-800-505-2653

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

OTC - PURPOSE SECTION

Active Ingredient (per tablet)	Purpose
Zincum Gluconicum 1X	Cold Remedy
Sambucus nigra 1X Eupatorium perfoliatum 1X	For temporary relief of flu symptoms (cough, nasal and chest congestion and irritated respiratory tract)
Mentha Piperita 2X	For temporary relief of cough
Myrrha 2X	For temporary relief of Sore Throat
Glycyrrhiza G. L. (Licorice Root) 3X	For temporary relief of Irritated Throat

Uses

INDICATIONS & USAGE SECTION

Take one QuickMelt every 2-4 hours per Directions on other side.

to reduce the duration of the common cold
reduces the severity of cold and flu symptoms: cough, sore throat, nasal and chest congestion post nasal drip and/or hoarseness
helps for temporary relief of Sore Throat

Warnings

WARNINGS SECTION

Ask a doctor before use if you

are taking minocycline, doxycycline, tetracycline or are on Coumadin therapy, as zinc treatment may inhibit the absorption of these medicines

OTC - STOP USE SECTION

Stop use and ask your healthcare practitioner if symptoms persist beyond 7 days.

SPL UNCLASSIFIED SECTION

Cold-EEZE^® Plus Multi-Symptom Relief Cold & Flu QuickMelts^® is a combination product formulated to help you to reduce the duration of the common cold and to help relieve Cold and Flu symptoms. It is insufficient treatment for Influenza or Allergies.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast feeding, ask a healthcare practitioner before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

Directions

DOSAGE & ADMINISTRATION SECTION

Take Cold-EEZE^® Plus Multi-Symptom Relief Cold & Flu QuickMelts^® when you have cold or flu symptoms
Adults:
- Dissolve entire tablet in mouth. Do not chew. Do not swallow whole
- Take 1 tablet at the onset of symptoms
- Repeat every 2-4 hours as needed until all symptoms subside
- Do not eat or drink for 15 minutes after use, otherwise, drink plenty of fluids
- Recommended daily dose is 6 tablets for adults and 4 tablets for ages 12-17 years
For children under 12 years of age, consult a healthcare practitioner before use

Other information

STORAGE AND HANDLING SECTION

Do not take Cold-EEZE^® Plus Multi-Symptom Relief Cold & Flu QuickMelts^® on an empty stomach to avoid possible minor stomach upset
Store in a cool and dry place

Inactive ingredients

INACTIVE INGREDIENT SECTION

beta carotene, crospovidone, glycine, magnesium stearate, malic acid, maltodextrin, mannitol, microcrystalline cellulose, natural honey crystals, natural honey lemon flavor, natural menthol flavor, polyethylene glycol, silicon dioxide, sodium lauryl sulfate, sodium starch glycolate, stevia, sucralose, talc.

Questions or Comments

OTC - QUESTIONS SECTION

Call 1-800-505-2653
(M-F: 9AM-5PM EST)

SPL UNCLASSIFIED SECTION

Manufactured for and
Distributed by:
ProPhase Labs, Inc.
P.O. Box 1349, Doylestown
PA 18901

PRINCIPAL DISPLAY PANEL - 24 Tablet Blister Pack Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NEW QuickMelts^®

GREAT
TASTE

Cold-EEZE^®

Zinc Gluconate Glycine

COLD REMEDY

Plus Natural
Multi-Symptom Relief

Cold & Flu

Shortens Your Cold, Works Faster™
+Helps Relieve:
- Cough
- Chest Congestion
- Sore Throat

24 QuickMelts^®
Homeopathic

Natural
Honey Lemon
Flavor

Principal Display Panel - 24 Tablet Blister Pack Carton

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
f47a510b-6679-4664-b2d6-47b5c4afe7cc	Product name	4	20260217
030ce964-9b2d-45aa-b5d3-f78ce03ef61c	Product name	2	20250515
0306390c-dd77-4363-afe0-63c58088b2a1	Product name	1	20220120
503ea967-4b9c-48cf-9e87-c7975295849d	Product name	2	20220120
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
190f2a5b-bbc8-65c7-fcb0-97891307b917	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
61941-0226-5	2020-01-31	C162847	48780-1	9d75b9d0-85ae-f424-e053-dadaa90a57ce	Cold-EEZE ® Natural Multi-Symptom Relief
61941-0226-6	2020-01-31	C162847	48780-1	9d75b9d0-85ae-f424-e053-dadaa90a57ce	Cold-EEZE ® Natural Multi-Symptom Relief

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
61941-0226-1	Cold-EEZE Natural Multi-Symptom Relief	6 in 1 BLISTER PACK	TABLET, ORALLY DISINTEGRATING	6	1
61941-0226-4	Cold-EEZE Natural Multi-Symptom Relief	4 in 1 BOX	TABLET, ORALLY DISINTEGRATING	4	1
61941-0226-5	Cold-EEZE Natural Multi-Symptom Relief	36 in 1 CASE	TABLET, ORALLY DISINTEGRATING	36	1
61941-0226-6	Cold-EEZE Natural Multi-Symptom Relief	48 in 1 CASE	TABLET, ORALLY DISINTEGRATING	48	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
61941-0226	COLD-EEZE NATURAL MULTI-SYMPTOM RELIEF (ZINC GLUCONATE, SAMBUCUS NIGRA FLOWER, EUPATORIUM PERFOLIATUM FLOWERING TOP, MENTHA PIPERITA, MYRRH, AND GLYCYRRHIZA GLABRA LEAF) TABLET, ORALLY DISINTEGRATING [PROPHASE LABS, INC.]	1	Legacy NDC, 4 package rows	20150114_a25b6a72-93b3-487a-9fb9-d33453a448ee.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
Eupatorium Perfoliatum Flowering Top	ACTIVE INGREDIENT	1W0775VX6E	1
Glycyrrhiza Glabra Leaf	ACTIVE INGREDIENT	GH32M797Y9	1
Mentha Piperita	ACTIVE INGREDIENT	79M2M2UDA9	1
Myrrh	ACTIVE INGREDIENT	JC71GJ1F3L	1
Sambucus Nigra Flower	ACTIVE INGREDIENT	07V4DX094T	1
Zinc Gluconate	ACTIVE INGREDIENT	U6WSN5SQ1Z	1
Eupatorium Perfoliatum Flowering Top	ACTIVE MOIETY	1W0775VX6E	1
Glycyrrhiza Glabra Leaf	ACTIVE MOIETY	GH32M797Y9	1
Mentha Piperita	ACTIVE MOIETY	79M2M2UDA9	1
Myrrh	ACTIVE MOIETY	JC71GJ1F3L	1
Sambucus Nigra Flower	ACTIVE MOIETY	07V4DX094T	1
Zinc Cation	ACTIVE MOIETY	13S1S8SF37	1
.Beta.-Carotene	INACTIVE INGREDIENT	01YAE03M7J	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	1
Crospovidone	INACTIVE INGREDIENT	68401960MK	1
Glycine	INACTIVE INGREDIENT	TE7660XO1C	1
Honey	INACTIVE INGREDIENT	Y9H1V576FH	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	1
MALIC ACID	INACTIVE INGREDIENT	817L1N4CKP	1
MALTODEXTRIN	INACTIVE INGREDIENT	7CVR7L4A2D	1
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	1
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	1
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	1
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	1
STEVIA REBAUDIUNA LEAF	INACTIVE INGREDIENT	6TC6NN0876	1
SUCRALOSE	INACTIVE INGREDIENT	96K6UQ3ZD4	1
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 25 matching rows.

Cold-EEZE Natural Multi-Symptom Relief
Zinc Gluconate, Sambucus Nigra Flower, Eupatorium Perfoliatum Flowering Top, Mentha Piperita, Myrrh, and Glycyrrhiza Glabra Leaf
Zinc Gluconate
Zinc Cation
Sambucus Nigra Flower
Eupatorium Perfoliatum Flowering Top
Mentha Piperita
Myrrh
Glycyrrhiza Glabra Leaf
Glycine
.Beta.-Carotene
Crospovidone
MAGNESIUM STEARATE
MALIC ACID
MALTODEXTRIN
MANNITOL
CELLULOSE, MICROCRYSTALLINE
Honey
POLYETHYLENE GLYCOLS
SILICON DIOXIDE
SODIUM LAURYL SULFATE
SODIUM STARCH GLYCOLATE TYPE A POTATO
STEVIA REBAUDIUNA LEAF
SUCRALOSE
TALC

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
61941-0226	61941-0226-1, 61941-0226-4, 61941-0226-5, 61941-0226-6

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 22 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
Zinc Gluconate	U6WSN5SQ1Z	ACTIB
Sambucus Nigra Flower	07V4DX094T	ACTIB
Eupatorium Perfoliatum Flowering Top	1W0775VX6E	ACTIB
Mentha Piperita	79M2M2UDA9	ACTIB
Myrrh	JC71GJ1F3L	ACTIB
Glycyrrhiza Glabra Leaf	GH32M797Y9	ACTIB
Glycine	TE7660XO1C	IACT
.Beta.-Carotene	01YAE03M7J	IACT
Crospovidone	68401960MK	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
MALIC ACID	817L1N4CKP	IACT
MALTODEXTRIN	7CVR7L4A2D	IACT
MANNITOL	3OWL53L36A	IACT
CELLULOSE, MICROCRYSTALLINE	OP1R32D61U	IACT
Honey	Y9H1V576FH	IACT
POLYETHYLENE GLYCOLS	3WJQ0SDW1A	IACT
SILICON DIOXIDE	ETJ7Z6XBU4	IACT
SODIUM LAURYL SULFATE	368GB5141J	IACT
SODIUM STARCH GLYCOLATE TYPE A POTATO	5856J3G2A2	IACT
STEVIA REBAUDIUNA LEAF	6TC6NN0876	IACT
SUCRALOSE	96K6UQ3ZD4	IACT
TALC	7SEV7J4R1U	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 6 · 322 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	POWDER, FOR SOLUTION / ORAL		414 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
Glycine	GLYCINE	TE7660XO1C	INJECTION, POWDER, FOR SOLUTION / INTRADERMAL	0.5 mg		Exact identifier — unii candidate 20 equally ranked IID candidates
MALTODEXTRIN	MALTODEXTRIN	7CVR7L4A2D	TABLET, CHEWABLE / ORAL	292 mg		Exact identifier — unii candidate 15 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS	35 mg		Exact identifier — unii candidate 65 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	GRANULE, FOR SUSPENSION / ORAL		6000 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET, CHEWABLE, EXTENDED RELEASE / ORAL		18 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET, SUGAR COATED / ORAL	NA		Exact identifier — unii candidate 35 equally ranked IID candidates
Glycine	GLYCINE	TE7660XO1C	CAPSULE, DELAYED RELEASE / ORAL		50 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	SOLUTION, GEL FORMING / DROPS / OPHTHALMIC		4 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
SODIUM LAURYL SULFATE	SODIUM LAURYL SULFATE	368GB5141J	SPONGE / TOPICAL	5 %w/w		Exact identifier — unii candidate 42 equally ranked IID candidates
SODIUM LAURYL SULFATE	SODIUM LAURYL SULFATE	368GB5141J	TABLET / ORAL		233 mg	Exact identifier — unii candidate 42 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	CAPSULE / ORAL		1562 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	CAPSULE, EXTENDED RELEASE / ORAL		117 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		615 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	GRANULE, FOR SUSPENSION / ORAL		23 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	CAPSULE, COATED PELLETS / ORAL		14 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
SODIUM LAURYL SULFATE	SODIUM LAURYL SULFATE	368GB5141J	GEL / TOPICAL	0.05 %w/w		Exact identifier — unii candidate 42 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET / SUBLINGUAL	17.5 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	CAPSULE, COATED PELLETS / ORAL	14 mg		Exact identifier — unii candidate 35 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	SOLUTION / ORAL		800 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	TABLET, CHEWABLE, EXTENDED RELEASE / ORAL		616 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	CAPSULE, DELAYED RELEASE / ORAL		420 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
Glycine	GLYCINE	TE7660XO1C	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS	10 mg		Exact identifier — unii candidate 20 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	CAPSULE, EXTENDED RELEASE / ORAL		1246 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
MALTODEXTRIN	MALTODEXTRIN	7CVR7L4A2D	LOZENGE / ORAL		175 mg	Exact identifier — unii candidate 15 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL		47 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	GRANULE, DELAYED RELEASE / ORAL	789.6 mg		Exact identifier — unii candidate 28 equally ranked IID candidates
MALTODEXTRIN	MALTODEXTRIN	7CVR7L4A2D	PASTE / ORAL		1050 mg	Exact identifier — unii candidate 15 equally ranked IID candidates
Glycine	GLYCINE	TE7660XO1C	INJECTION / INTRAMUSCULAR		68 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	CAPSULE / ORAL	256.4 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
Glycine	GLYCINE	TE7660XO1C	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS	200 mg		Exact identifier — unii candidate 20 equally ranked IID candidates
SODIUM LAURYL SULFATE	SODIUM LAURYL SULFATE	368GB5141J	CAPSULE, COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 42 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, DELAYED RELEASE / ORAL		144 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	TABLET, COATED / ORAL	177.7 mg		Exact identifier — unii candidate 65 equally ranked IID candidates
MALTODEXTRIN	MALTODEXTRIN	7CVR7L4A2D	SOLUTION / ORAL		1451 mg	Exact identifier — unii candidate 15 equally ranked IID candidates
SODIUM LAURYL SULFATE	SODIUM LAURYL SULFATE	368GB5141J	CAPSULE, COATED PELLETS / ORAL		1 mg	Exact identifier — unii candidate 42 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, CHEWABLE, EXTENDED RELEASE / ORAL		2 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	GRANULE / ORAL		322 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	CONCENTRATE / INTRAVENOUS		220 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	IMPLANT / INTRAVITREAL	NA		Exact identifier — unii candidate 39 equally ranked IID candidates
SODIUM LAURYL SULFATE	SODIUM LAURYL SULFATE	368GB5141J	TABLET, ORALLY DISINTEGRATING / ORAL		16 mg	Exact identifier — unii candidate 42 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	DROPS / ORAL	NA		Exact identifier — unii candidate 49 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS		658 mg	Exact identifier — unii candidate 65 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	CAPSULE, COATED PELLETS / ORAL		456 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	SUSPENSION/ DROPS / TOPICAL	0.3 %w/v		Exact identifier — unii candidate 65 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, DELAYED RELEASE / ORAL		1190 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SODIUM LAURYL SULFATE	SODIUM LAURYL SULFATE	368GB5141J	GEL / VAGINAL	0.2 %w/w		Exact identifier — unii candidate 42 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	GRANULE / ORAL	5000 mg		Exact identifier — unii candidate 49 equally ranked IID candidates
SODIUM LAURYL SULFATE	SODIUM LAURYL SULFATE	368GB5141J	PELLET / ORAL		2 mg	Exact identifier — unii candidate 42 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	LOZENGE / ORAL		115 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	CAPSULE / RESPIRATORY (INHALATION)	NA		Exact identifier — unii candidate 49 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	SUSPENSION, EXTENDED RELEASE / ORAL		46 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	LOZENGE / TRANSMUCOSAL		100 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET / ORAL	1000 mg		Exact identifier — unii candidate 35 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET / SUBLINGUAL	32.4 mg		Exact identifier — unii candidate 35 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, COATED / ORAL		184 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, EXTENDED RELEASE / ORAL		173 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	CAPSULE, LIQUID FILLED / ORAL		106 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	TABLET, CHEWABLE / ORAL		28 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
TALC	TALC	7SEV7J4R1U	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		60 mg	Exact identifier — unii candidate 35 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
cdd481e7-f120-40ad-999e-1de9186f62bd			a25b6a72-93b3-487a-9fb9-d33453a448ee	2014-11-24	Warnings	Exact identifier spl id: cdd481e7-f120-40ad-999e-1de9186f62bd spl set id: a25b6a72-93b3-487a-9fb9-d33453a448ee

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.